https://www.selleckchem.com/products/vtp50469.html
0074). We conclude that the increase in circulating tumor DNA values collected in peripheral blood after the first cycle of systemic treatment in patients with advanced ovarian cancer is associated with an early response to systemic treatment and correlates with superior disease-free survival in this population. Circulating tumor DNA might be a specific, noninvasive, and cost-effective new biomarker of early response to systemic treatment in these patients.False smut of rice, caused by Ustilaginoidea virens, has become one of the most
Like
Comment
Share
